Andres Hidalgo
Overview
Explore the profile of Andres Hidalgo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
148
Citations
9630
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ng M, Cerezo-Wallis D, Ng L, Hidalgo A
Immunity
. 2025 Jan;
58(1):40-58.
PMID: 39813993
There is a renewed interest in neutrophil biology, largely instigated by their prominence in cancer. From an immunologist's perspective, a conceptual breakthrough is the realization that prototypical inflammatory, cytotoxic leukocytes...
2.
Nicolas-Avila J, Hidalgo A
Nat Cardiovasc Res
. 2024 Aug;
1(7):603-604.
PMID: 39196238
No abstract available.
3.
Ruscitti C, Abinet J, Marechal P, Meunier M, de Meeus C, Vanneste D, et al.
Sci Immunol
. 2024 Aug;
9(98):eado1227.
PMID: 39093958
The lung is constantly exposed to airborne pathogens and particles that can cause alveolar damage. Hence, appropriate repair responses are essential for gas exchange and life. Here, we deciphered the...
4.
Weinberger T, Denise M, Joppich M, Fischer M, Garcia Rodriguez C, Kumaraswami K, et al.
Elife
. 2024 May;
12.
PMID: 38775664
Cardiac macrophages are heterogenous in phenotype and functions, which has been associated with differences in their ontogeny. Despite extensive research, our understanding of the precise role of different subsets of...
5.
Ghodsi A, Hidalgo A, Libreros S
Curr Opin Hematol
. 2024 May;
31(4):175-192.
PMID: 38727155
Purpose Of Review: Acute inflammation is the body's first defense in response to pathogens or injury. Failure to efficiently resolve the inflammatory insult can severely affect tissue homeostasis, leading to...
6.
Klemt I, Reshetnikov V, Dutta S, Bila G, Bilyy R, Cuartero I, et al.
RSC Med Chem
. 2024 Apr;
15(4):1189-1197.
PMID: 38665843
Many known chemotherapeutic anticancer agents exhibit neutropenia as a dose-limiting side effect. In this paper we suggest a prodrug concept solving this problem for camptothecin (HO-cpt). The prodrug is programmed...
7.
Swanton C, Bernard E, Abbosh C, Andre F, Auwerx J, Balmain A, et al.
Cell
. 2024 Mar;
187(7):1589-1616.
PMID: 38552609
The last 50 years have witnessed extraordinary developments in understanding mechanisms of carcinogenesis, synthesized as the hallmarks of cancer. Despite this logical framework, our understanding of the molecular basis of...
8.
Aroca-Crevillen A, Vicanolo T, Ovadia S, Hidalgo A
Annu Rev Pathol
. 2024 Jan;
19:227-259.
PMID: 38265879
Infections, cardiovascular disease, and cancer are major causes of disease and death worldwide. Neutrophils are inescapably associated with each of these health concerns, by either protecting from, instigating, or aggravating...
9.
Zhang N, Tang W, Torres L, Wang X, Ajaj Y, Zhu L, et al.
Cell
. 2024 Jan;
187(4):846-860.e17.
PMID: 38262409
RNAs localizing to the outer cell surface have been recently identified in mammalian cells, including RNAs with glycan modifications known as glycoRNAs. However, the functional significance of cell surface RNAs...
10.
Ng M, Kwok I, Tan L, Shi C, Cerezo-Wallis D, Tan Y, et al.
Science
. 2024 Jan;
383(6679):eadf6493.
PMID: 38207030
Neutrophils are increasingly recognized as key players in the tumor immune response and are associated with poor clinical outcomes. Despite recent advances characterizing the diversity of neutrophil states in cancer,...